دوره 10، شماره 3 - ( 6-1401 )
جلد 10 شماره 3 صفحات 31-24 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Afshari M, Kheradmand M, Aarabi M, Parsaee M, Roozbeh F, Nezammahalleh A, et al . Co-morbidity of Diabetes and Tuberculosis Can Affect the Results of Treatment; A Case Control Study in Iran. Iran J Health Sci 2022; 10 (3) :24-31
URL: http://jhs.mazums.ac.ir/article-1-824-fa.html
URL: http://jhs.mazums.ac.ir/article-1-824-fa.html
افشاری مهدی، خردمند مطهره، اعرابی مخسن، پارسایی مخمدرضا، روزبه فاطمه، نظام محله اصغر، و همکاران.. Co-morbidity of Diabetes and Tuberculosis Can Affect the Results of Treatment; A Case Control Study in Iran. علوم بهداشتی ایران. 1401; 10 (3) :24-31
مهدی افشاری 
، مطهره خردمند ، مخسن اعرابی ، مخمدرضا پارسایی ، فاطمه روزبه ، اصغر نظام محله ، کیوان حیدری ، مریم زکیان ، محمود موسی زاده*
، مطهره خردمند ، مخسن اعرابی ، مخمدرضا پارسایی ، فاطمه روزبه ، اصغر نظام محله ، کیوان حیدری ، مریم زکیان ، محمود موسی زاده*
، mmoosazadeh1351@gmail.com
چکیده: (1901 مشاهده)
Background and Purpose: Several evidences have shown some synergistic effect of diabetes co-morbidity on the tuberculosis (TB) treatment results, while some other studies have not found such associations. This study aimed to investigate the relationship between TB-diabetes co-morbidity and outcomes of TB treatment.
Materials and Methods: The research population in this case control study were patients with smear positive tuberculosis. The cases were 158 patients with TB and diabetes selected by consensus method, while controls were 316 patients randomly selected from TB patients without diabetes.
Results: Frequency of unfavorable outcome among cases was higher than among controls (7.6% vs 7.3% respectively, p-value =0.901). Multivariate logistic regression models showed that the odds ratios for adverse treatment outcome, death, treatment failure, positive smear after the intensive phase of treatment and high grade positivity (2+ & 3+) were 0.97(0.45- 2.06), 0.97(0.42-2.24), 0.91(0.17-4.85), 1.39(0.79- 2.44) and 2.57(0.83- 7.92) respectively. Moreover, treatment adverse outcomes among patients with drug complications (22.2% vs. 6.5%, p-value =0.010) and rural residents (10% vs 4.9% respectively, p-value =0.037) were significantly higher than those among patients without complication and urban residents respectively.
Conclusion: Although we did not observe any significant association between TB-diabetes co-morbidity and treatment results, there was a significant effect measure regarding the effect of smear positivity at the end of the intensive phase of treatment, especially high grade of smear positivity. Because of probable bias in the classification of the exposure, screening of TB patients regarding diabetes mellitus at the beginning of the treatment is recommended.
Materials and Methods: The research population in this case control study were patients with smear positive tuberculosis. The cases were 158 patients with TB and diabetes selected by consensus method, while controls were 316 patients randomly selected from TB patients without diabetes.
Results: Frequency of unfavorable outcome among cases was higher than among controls (7.6% vs 7.3% respectively, p-value =0.901). Multivariate logistic regression models showed that the odds ratios for adverse treatment outcome, death, treatment failure, positive smear after the intensive phase of treatment and high grade positivity (2+ & 3+) were 0.97(0.45- 2.06), 0.97(0.42-2.24), 0.91(0.17-4.85), 1.39(0.79- 2.44) and 2.57(0.83- 7.92) respectively. Moreover, treatment adverse outcomes among patients with drug complications (22.2% vs. 6.5%, p-value =0.010) and rural residents (10% vs 4.9% respectively, p-value =0.037) were significantly higher than those among patients without complication and urban residents respectively.
Conclusion: Although we did not observe any significant association between TB-diabetes co-morbidity and treatment results, there was a significant effect measure regarding the effect of smear positivity at the end of the intensive phase of treatment, especially high grade of smear positivity. Because of probable bias in the classification of the exposure, screening of TB patients regarding diabetes mellitus at the beginning of the treatment is recommended.
نوع مطالعه: پژوهشي |
موضوع مقاله:
اپيدميولوژي
ارسال پیام به نویسنده مسئول
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
